(Total Views: 112)
Posted On: 05/21/2025 9:03:15 AM
Post# of 2459

2025 Q1 Filed May 20, 2025 - Key Points
At March 31, 2025 vs December 31, 2024
Total Assets:$219,968,195 vs $19,968,195 - up $200,000,000 - up 1,001%
March 31, 2025 vs March 31, 2024
Revenue: $431,618 vs $231,440 - up $200,178 - up 86.5%
Total Expenses: $85,636 vs $162,948 - down $77,312 - down 47.4%
Net Operating Gain: $345,982 vs $68,492 - up $277,490 - up 40.5%
Retained Earnings: $3,281,420 vs $2,717,707 - up $563,713 - up 20.7%
At March 31, 2025 vs December 31, 2024
Total Assets:$219,968,195 vs $19,968,195 - up $200,000,000 - up 1,001%
March 31, 2025 vs March 31, 2024
Revenue: $431,618 vs $231,440 - up $200,178 - up 86.5%
Total Expenses: $85,636 vs $162,948 - down $77,312 - down 47.4%
Net Operating Gain: $345,982 vs $68,492 - up $277,490 - up 40.5%
Retained Earnings: $3,281,420 vs $2,717,707 - up $563,713 - up 20.7%


"Per Ardua Ad Astra" - "Through Adversity To The Stars"
A very apposite motto for those who trade successfully in the OTC market..
All posts are my opinion - trade at your own risk.
A very apposite motto for those who trade successfully in the OTC market..
All posts are my opinion - trade at your own risk.